Cleared Traditional

K863054 - AST S.C.E. (GOT)

K863054 is the FDA 510(k) clearance for AST S.C.E. (GOT) by J. D. Assoc.. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K863054 · J. D. Assoc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1987
Decision
154d
Days
Class 2
Risk

K863054 is an FDA 510(k) clearance for the AST S.C.E. (GOT). Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by J. D. Assoc. (Montclair, US). The FDA issued a Cleared decision on January 13, 1987 after a review of 154 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all J. D. Assoc. devices

Submission Details

510(k) Number K863054 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 1986
Decision Date January 13, 1987
Days to Decision 154 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d slower than avg
Panel avg: 88d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 106
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K863054.
REFLOTRON(R) AST (GOT)
K870246 · Boehringer Mannheim Corp. · Feb 1987
WAKO (TM) AUTOKIT GOT TEST
K864813 · Wako Chemicals USA, Inc. · Feb 1987
AST(GOT) (ASPARTATE AMINOTRANSFERASE) REAGENT
K864357 · Trace Scientific , Ltd. · Feb 1987
WAKO(TM) GOT II - HA
K864302 · Wako Chemicals USA, Inc. · Dec 1986
EMDS(TM) ASPARTATE AMINOTRANSFERASE (AST) 67657/95
K863963 · Em Diagnostic Systems, Inc. · Nov 1986
AST/GOT PROCEDURE
K863257 · Data Medical Associates, Inc. · Sep 1986